Addressing Industry Challenges with Proven Science
At the recent Innovation Day seminar hosted by Complementary Medicines Australia (CMA), Gnosis by Lesaffre, led by Jose Pinedo Rivera, Product Manager, had the opportunity to present MyCondro™ to an engaged audience of over 250 industry professionals. The session, “Keeping Pace with a Changing World: MyCondro™ Disrupts the Chondroitin Sulfate Market,” was well received, sparking interest and conversations around the future of joint health solutions.
MyCondro™ stood out as a breakthrough solution addressing the limitations of animal-based chondroitin, including supply chain variability, risk of contamination, and ethical concerns. Through the presentation, Gnosis highlighted how this fermentation-derived ingredient delivers 45% higher bioavailability, proven clinical efficacy at a lower dosage, and consistent purity that surpasses regulatory standards. As the world shifts toward cleaner, more responsible nutraceuticals, MyCondro™ emerged as a compelling option for brands looking to innovate and meet consumer expectations.
Engaging One-to-One: Bringing Innovation Closer
In addition to the presentation, The Gnosis booth at the CMA event allowed connection with attendees in more personal, one-to-one discussions. These interactions offered a valuable platform to explain further why MyCondro™ matters—its scientific foundation, production innovation, and potential for expanded applications in areas like metabolic health and inflammation management. Overall, the seminar was a successful moment to communicate not just what Gnosis offers, but why and how the company is leading the transformation of the joint health category.
Furthermore, the structure of MyCondro™ closely resembles human synovial fluid, which may contribute to its efficacy in promoting joint health. Its low molecular weight and homogeneous composition enhance its bioactivity, making it a promising option for individuals seeking to maintain joint function and mobility.
Discover MyCondro™
Chondroitin sulfate has been traditionally sourced from animals, but concerns over cross-contamination and manufacturing processes, as driven demand for a non-animal source of this key nutrient. Gnosis by Lesaffre is proud to fulfill this demand with its revolutionary ingredient MyCondro™.
